JiangXi Tianxin Pharm Co Ltd (603235) — Cash Flow Reinvestment Rate
JiangXi Tianxin Pharm Co Ltd (603235) has a Cash Flow Reinvestment Rate of 0.92x as of December 2025, reinvesting CN¥580.68 Million (capex CN¥580.68 Million ) from operating cash flow of CN¥629.36 Million. Explore JiangXi Tianxin Pharm Co Ltd capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
JiangXi Tianxin Pharm Co Ltd Cash Flow Reinvestment Rate (2020–2025)
Historical reinvestment intensity for JiangXi Tianxin Pharm Co Ltd across 6 annual periods. Also explore 603235 total assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year capital reinvestment analysis for JiangXi Tianxin Pharm Co Ltd. For live market cap and broader valuation context, see JiangXi Tianxin Pharm Co Ltd (603235) total market value.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.92x | CN¥580.68 Million | CN¥629.36 Million | CN¥580.68 Million | ▼ -82.3% |
| 2024 | 5.22x | CN¥2.61 Billion | CN¥499.66 Million | CN¥1.07 Billion | ▲ +353.7% |
| 2023 | 1.15x | CN¥838.75 Million | CN¥729.21 Million | CN¥535.60 Million | ▼ -2.5% |
| 2022 | 1.18x | CN¥715.84 Million | CN¥606.61 Million | CN¥260.50 Million | ▲ +112.3% |
| 2021 | 0.56x | CN¥455.04 Million | CN¥818.63 Million | CN¥215.50 Million | ▲ +7.7% |
| 2020 | 0.52x | CN¥600.51 Million | CN¥1.16 Billion | CN¥303.04 Million | — |